Furthermore, we identified GAMs as the predominant source for the pro-tumorigenic proteins GPNMB and SPP1 in murine and human malignant glioma – highlighting the importance of macrophages and microglia as therapeutic targets in anti-tumor treatment regimens. This evidence concerns the gene SPP1 and malignant glioma.